Praluent Outcomes- were screwed

Discussion in 'Amgen' started by anonymous, Sep 15, 2018 at 2:47 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Managed care will completely tip to Praluent moving into 2019. Despite our management desperate attempts to bring the patent suit back there's a zero chance the Supreme Court would give a shit. Plan B for all of us in 2019. Fourier showed nothing and we have no mortality data. We fucked up.
     

  2. anonymous

    anonymous Guest

    Funny you mention this. Card at lunch yesterday wanted to know why we didn't have data on high risk patients or show any mortality benefit. I think this will come up more especially when we get locked out of managed care. The Patent suit will be 2 years away if were dumb enough to try and waste legal money on a lost cause.
     
  3. anonymous

    anonymous Guest

  4. anonymous

    anonymous Guest

    PCSK9 wont go away but Repatha will be limited in managed care as we dont have data nearly as good as Praluent. We showed nothing earth shattering with Fourier. No comparison to Oydsessy